A Mixture of Morus alba and Angelica keiskei Leaf Extracts Improves Muscle Atrophy by Activating the PI3K/Akt/mTOR Signaling Pathway and Inhibiting FoxO3a In Vitro and In Vivo
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Muscle atrophy, which is defined as a decrease in muscle mass and strength, is caused by an imbalance between the anabolism and catabolism of muscle proteins. Thus, modulating the homeostasis between muscle protein synthesis and degradation represents an efficient treatment approach for this condition. In the present study, the protective effects against muscle atrophy of ethanol extracts of Morus alba L. (MA) and Angelica keiskei Koidz. (AK) leaves and their mixtures (MIX) were evaluated in vitro and in vivo. Our results showed that MIX increased 5-aminoimidazole4-carboxamide ribonucleotide-induced C2C12 myotube thinning, and enhanced soleus and gastrocnemius muscle thickness compared to each extract alone in dexamethasone-induced muscle atrophy Sprague Dawley rats. In addition, although MA and AK substantially improved grip strength and histological changes for dexamethasone-induced muscle atrophy in vivo, the efficacy was superior in the MIX-treated group. Moreover, MIX further increased the expression levels of myogenic factors (MyoD and myogenin) and decreased the expression levels of E3 ubiquitin ligases (atrogin-1 and muscle-specific RING finger protein-1) in vitro and in vivo compared to the MA- and AK-alone treatment groups. Furthermore, MIX increased the levels of phosphorylated phosphoinositide 3-kinase (PI3K), protein kinase B (Akt), and mammalian target of rapamycin (mTOR) that were reduced by dexamethasone, and downregulated the expression of forkhead box O3 (FoxO3a) induced by dexamethasone. These results suggest that MIX has a protective effect against muscle atrophy by enhancing muscle protein anabolism through the activation of the PI3K/Akt/mTOR signaling pathway and attenuating catabolism through the inhibition of FoxO3a.
Abstract
Muscle atrophy, which is defined as a decrease in muscle mass and strength, is caused by an imbalance between the anabolism and catabolism of muscle proteins. Thus, modulating the homeostasis between muscle protein synthesis and degradation represents an efficient treatment approach for this condition. In the present study, the protective effects against muscle atrophy of ethanol extracts of Morus alba L. (MA) and Angelica keiskei Koidz. (AK) leaves and their mixtures (MIX) were evaluated in vitro and in vivo. Our results showed that MIX increased 5-aminoimidazole4-carboxamide ribonucleotide-induced C2C12 myotube thinning, and enhanced soleus and gastrocnemius muscle thickness compared to each extract alone in dexamethasone-induced muscle atrophy Sprague Dawley rats. In addition, although MA and AK substantially improved grip strength and histological changes for dexamethasone-induced muscle atrophy in vivo, the efficacy was superior in the MIX-treated group. Moreover, MIX further increased the expression levels of myogenic factors (MyoD and myogenin) and decreased the expression levels of E3 ubiquitin ligases (atrogin-1 and muscle-specific RING finger protein-1) in vitro and in vivo compared to the MA- and AK-alone treatment groups. Furthermore, MIX increased the levels of phosphorylated phosphoinositide 3-kinase (PI3K), protein kinase B (Akt), and mammalian target of rapamycin (mTOR) that were reduced by dexamethasone, and downregulated the expression of forkhead box O3 (FoxO3a) induced by dexamethasone. These results suggest that MIX has a protective effect against muscle atrophy by enhancing muscle protein anabolism through the activation of the PI3K/Akt/mTOR signaling pathway and attenuating catabolism through the inhibition of FoxO3a.
참고문헌 (50)
- Dos Santos L, "Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function", J. Cachexia Sarcopenia Muscle, 8, pp.245~250 (2017)
- Barbalho SM, "Physical exercise and myokines:relationships with sarcopenia and cardiovascular complications", Int. J. Mol. Sci, 21, pp.3607~ (2020)
- Lara-Castillo N, "Bone-muscle mutual interactions", Curr. Osteoporos. Rep, 18, pp.408~421 (2020)
- Schiaffino S, "Mechanisms regulating skeletal muscle growth and atrophy", FEBS J, 280, pp.4294~4314 (2013)
- Peris-Moreno D, "Ubiquitin ligases at the heart of skeletal muscle atrophy control", Molecules, 26, pp.407~ (2021)
- Wang Y, "Nutraceuticals in the prevention and treatment of the muscle atrophy", Nutrients, 13, pp.1914~ (2021)
- Nunes EA, "Disuse-induced skeletal muscle atrophy in disease and nondisease states in humans: mechanisms, prevention, and recovery strategies", Am. J. Physiol. Cell. Physiol, 322, pp.C1068~C1084 (2022)
- Wang K, "Chronic kidney disease-induced muscle atrophy: molecular mechanisms and promising therapies", Biochem. Pharmacol, 208, pp.115407~ (2023)
- Powers SK, "Disease-induced skeletal muscle atrophy and fatigue", Med. Sci. Sports Exerc, 48, pp.2307~2319 (2016)
- Thomson DM, "The role of AMPK in the regulation of skeletal muscle size, hypertrophy, and regeneration", Int. J. Mol. Sci, 19, pp.3125~ (2018)
- Sukumaran A, "Insight on transcriptional regulation of the energy sensing AMPK and biosynthetic mTOR pathway genes", Front. Cell. Dev. Biol, 8, pp.671~ (2020)
- Ahsan M, "The bidirectional relationship between AMPK pathway activation and myokine secretion in skeletal muscle: how it affects energy metabolism", Front. Physiol, 13, pp.1040809~ (2022)
- Sharples AP, "Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intake", Aging Cell, 14, pp.511~523 (2015)
- Yoon MS, "mTOR as a key regulator in maintaining skeletal muscle mass", Front. Physiol, 8, pp.788~ (2017)
- Zungu M, "Regulation of AMPK by the ubiquitin proteasome system", Am. J. Pathol, 178, pp.4~11 (2011)
- Singh A, "The dependency of autophagy and ubiquitin proteasome system during skeletal muscle atrophy", Biophys. Rev, 13, pp.203~219 (2021)
- Lee MK, "Nutrients against glucocorticoid-induced muscle atrophy", Foods, 11, pp.687~ (2022)
- Oray M, "Long-term side effects of glucocorticoids", Expert. Opin. Drug Saf, 15, pp.457~465 (2016)
- Timmermans S, "A general introduction to glucocorticoid biology", Front. Immunol, 10, pp.1545~ (2019)
- Stitt TN, "The IGF-1", PI3K, Mol. Cell, pp.2004, 14[DOI]
- Wang P, "Monotropein improves dexamethasone-induced muscle atrophy via the AKT", mTOR, Nutrients, pp.2022, 14[DOI]
- Haberecht-Müller S, "Out of control: The role of the ubiquitin proteasome system in skeletal muscle during inflammation", Biomolecules, 11, pp.1327~ (2021)
- Hanai J, "The muscle-specific ubiquitin ligase atrogin-1", MAFbx mediates statin-induced muscle toxicity, 2007, pp.117, 3940~3951
- Shirakawa T, "Factors regulating or regulated by myogenic regulatory factors in skeletal muscle stem cells", Cells, 11, pp.1493~ (2022)
- Morales Ramos JG, "Medicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review", F1000Res, 10, pp.1022~ (2021)
- Jeong HI, "Morus alba L. for blood sugar management: a systematic review and meta-analysis", Evid. Based Complement. Alternat. Med, 2022, pp.9282154~ (2022)
- Zhang R, "Mulberry leaf (Morus alba L.): a review of its potential influences in mechanisms of action on metabolic diseases", Pharmacol. Res, 175, pp.106029~ (2022)
- Wani MY, "The phenolic components extracted from mulberry fruits as bioactive compounds against cancer: a review", Phytother. Res, 37, pp.1136~1152 (2023)
- Nagata J, "Effects of dietary Angelica keiskei on serum and liver lipid profiles, and body fat accumulations in rats", J. Nutr. Sci. Vitaminol. (Tokyo), 53, pp.133~137 (2007)
- Zhang C, "Daily supplementation with fresh Angelica keiskei juice alleviates high-fat diet-induced obesity in mice by modulating gut microbiota composition", Mol. Nutr. Food Res, 63, pp.e1900248~ (2019)
- 길윤서, "Angelica keiskei, an emerging medicinal herb with various bioactive constituents and biological activities", Archives of Pharmacal Research, 40(6), pp.655~675 (2017), 대한약학회
- Miranowicz-Dzierżawska Katarzyna, "The effects of co-exposure to methyl paraben and dibutyl phthalate on cell line derived from human skin", 한국독성학회지, 39(1), pp.71~89 (2023), 한국독성학회[DOI]
- Park Cheol, "The preventive effect of Mori Ramulus on oxidative stress-induced cellular damage in skeletal L6 myoblasts through Nrf2-mediated activation of HO-1", 한국독성학회지, 39(1), pp.25~36 (2023), 한국독성학회[DOI]
- Murad-Ali Shah, "Epigallocatechin gallate restores the reduction of protein phosphatase 2 A subunit B caused by middle cerebral artery occlusion", Laboratory Animal Research, 39(1), pp.26~36 (2023), 한국실험동물학회[DOI]
- 이나윤, "SARS-CoV-2 Omicron variant causes brain infection with lymphoid depletion in a mouse COVID-19 model", Laboratory Animal Research, 39(2), pp.165~171 (2023), 한국실험동물학회[DOI]
- 이혜숙, "Schisandrae Fructus ethanol extract attenuates particulate matter 2.5-induced inflammatory and oxidative responses by blocking the activation of the ROS-dependent NF-κB signaling pathway", Nutrition Research and Practice, 15(6), pp.686~702 (2021), 한국영양학회[DOI]
- Sampath SC, "Myoblast fusion confusion: the resolution begins", Skelet. Muscle, 8, pp.3~ (2018)
- Blais A, "An initial blueprint for myogenic differentiation", Genes Dev, 19, pp.553~569 (2005)
- Tong JF, "AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1", Akt signaling in C2C12 myotubes, 2009, pp.108, 458~468
- Sartori R, "Mechanisms of muscle atrophy and hypertrophy: implications in health and disease", Nat. Commun, 12, pp.330~ (2021)
- Wang L, "Trimetazidine attenuates dexamethasone-induced muscle atrophy via inhibiting NLRP3", GSDMD pathway-mediated pyroptosis, 2021, pp.7, 251~
- Hah YS, "β-Sitosterol attenuates dexamethasone-induced muscle atrophy via regulating FoxO1-dependent signaling in C2C12 cell and mice model", Nutrients, 14, pp.2894~ (2022)
- Macedo AG, "Effects of exercise training on glucocorticoid-induced muscle atrophy: literature review", Steroids, 195, pp.109240~ (2023)
- Kang CW, "Mulberry (Morus alba L.) leaf extract and 1-deoxynojirimycin improve skeletal muscle insulin resistance via the activation of IRS-1", PI3K, db mice, pp.Life (Basel), 2022[DOI]
- Meng Q, "Flavonoids extracted from mulberry (Morus alba L.) leaf improve skeletal muscle mitochondrial function by activating AMPK in type 2 diabetes", J. Ethnopharmacol, 248, pp.112326~ (2020)
- Kweon M, "A chalcone from Ashitaba (Angelica keiskei) stimulates myoblast differentiation and inhibits dexamethasone-induced muscle atrophy", Nutrients, 11, pp.2419~ (2019)
- Yoshioka Y, "4-Hydroxyderricin and xanthoangelol isolated from Angelica keiskei prevent dexamethasone-induced muscle loss", Food Funct, 11, pp.5498~5512 (2020)
- Yoshida T, "Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy", Cells, 9, pp.1970~ (2020)
- Zheng B, "FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1", MAFbx expression during glucocorticoid-induced skeletal muscle atrophy, 2010, pp.24, 2660~2669
- Pedrosa MB, "Chemotherapy-induced molecular changes in skeletal muscle", Biomedicines, 11, pp.905~ (2023)